Literature DB >> 22180526

Pharmacogenomics of HIV therapy: summary of a workshop sponsored by the National Institute of Allergy and Infectious Diseases.

David W Haas1, Daniel R Kuritzkes, Marylyn D Ritchie, Shashi Amur, Brian F Gage, Gary Maartens, Dan Masys, Jacques Fellay, Elizabeth Phillips, Heather J Ribaudo, Kenneth A Freedberg, Christos Petropoulos, Teri A Manolio, Roy M Gulick, Richard Haubrich, Peter Kim, Marjorie Dehlinger, Rahel Abebe, Amalio Telenti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 22180526      PMCID： PMC3322423          DOI： 10.1310/hct1205-277

Source DB:  PubMed          Journal:  HIV Clin Trials        ISSN： 1528-4336


× No keyword cloud information.
  30 in total

1.  Impact of single nucleotide polymorphisms and of clinical risk factors on new‐onset diabetes mellitus in HIV‐infected individuals.

Authors:  Margalida Rotger; Thomas Gsponer; Raquel Martinez; Patrick Taffé; Luigia Elzi; Pietro Vernazza; Matthias Cavassini; Enos Bernasconi; Bernard Hirschel; Hansjakob Furrer; Rainer Weber; Bruno Ledergerber; Matthias Egger; Amalio Telenti; Philip E Tarr
Journal:  Clin Infect Dis       Date:  2010-11-01       Impact factor: 9.079

2.  Development of a large-scale de-identified DNA biobank to enable personalized medicine.

Authors:  D M Roden; J M Pulley; M A Basford; G R Bernard; E W Clayton; J R Balser; D R Masys
Journal:  Clin Pharmacol Ther       Date:  2008-05-21       Impact factor: 6.875

3.  Influence of CYP2B6 polymorphism on plasma and intracellular concentrations and toxicity of efavirenz and nevirapine in HIV-infected patients.

Authors:  Margalida Rotger; Sara Colombo; Hansjakob Furrer; Gabriela Bleiber; Thierry Buclin; Belle L Lee; Olivia Keiser; Jérôme Biollaz; Laurent Décosterd; Amalio Telenti
Journal:  Pharmacogenet Genomics       Date:  2005-01       Impact factor: 2.089

4.  Cytochrome P450 2B6 516G-->T is associated with plasma concentrations of nevirapine at both 200 mg twice daily and 400 mg once daily in an ethnically diverse population.

Authors:  Tw Mahungu; Cj Smith; F Turner; D Egan; M Youle; Ma Johnson; S Khoo; Dj Back; A Owen
Journal:  HIV Med       Date:  2009-02-17       Impact factor: 3.180

5.  Pharmacogenetics-based population pharmacokinetic analysis of efavirenz in HIV-1-infected individuals.

Authors:  M Arab-Alameddine; J Di Iulio; T Buclin; M Rotger; R Lubomirov; M Cavassini; A Fayet; L A Décosterd; C B Eap; J Biollaz; A Telenti; C Csajka
Journal:  Clin Pharmacol Ther       Date:  2009-02-18       Impact factor: 6.875

6.  HLA-B*3505 allele is a strong predictor for nevirapine-induced skin adverse drug reactions in HIV-infected Thai patients.

Authors:  Soranun Chantarangsu; Taisei Mushiroda; Surakameth Mahasirimongkol; Sasisopin Kiertiburanakul; Somnuek Sungkanuparph; Weerawat Manosuthi; Woraphot Tantisiriwat; Angkana Charoenyingwattana; Thanyachai Sura; Wasun Chantratita; Yusuke Nakamura
Journal:  Pharmacogenet Genomics       Date:  2009-02       Impact factor: 2.089

7.  Influence of CYP2B6 polymorphisms on the persistence of plasma nevirapine concentrations following a single intra-partum dose for the prevention of mother to child transmission in HIV-infected Thai women.

Authors:  Soranun Chantarangsu; Tim R Cressey; Surakameth Mahasirimongkol; Edmund Capparelli; Yardpiroon Tawon; Nicole Ngo-Giang-Huong; Gonzague Jourdain; Marc Lallemant; Wasun Chantratita
Journal:  J Antimicrob Chemother       Date:  2009-10-06       Impact factor: 5.790

8.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

9.  HLA-DRB1*01 associated with cutaneous hypersensitivity induced by nevirapine and efavirenz.

Authors:  Zulma G Vitezica; Brigitte Milpied; Christine Lonjou; Nicolas Borot; Terence Niel Ledger; Anne Lefebvre; Alain Hovnanian
Journal:  AIDS       Date:  2008-02-19       Impact factor: 4.177

10.  Associations among race/ethnicity, ApoC-III genotypes, and lipids in HIV-1-infected individuals on antiretroviral therapy.

Authors:  Andrea S Foulkes; David A Wohl; Ian Frank; Elaine Puleo; Stephanie Restine; Megan L Wolfe; Michael P Dube; Pablo Tebas; Muredach P Reilly
Journal:  PLoS Med       Date:  2006-03       Impact factor: 11.069
View more
  7 in total

Review 1.  The other genome: a systematic review of studies of mitochondrial DNA haplogroups and outcomes of HIV infection and antiretroviral therapy.

Authors:  Anna B Hart; David C Samuels; Todd Hulgan
Journal:  AIDS Rev       Date:  2013 Oct-Dec       Impact factor: 2.500

2.  Cost-effectiveness analysis of UGT1A1 genetic testing to inform antiretroviral prescribing in HIV disease.

Authors:  Bruce R Schackman; David W Haas; Jessica E Becker; Bethany K Berkowitz; Paul E Sax; Eric S Daar; Heather J Ribaudo; Kenneth A Freedberg
Journal:  Antivir Ther       Date:  2012-12-21

Review 3.  Clinical pharmacokinetics of antiretroviral drugs in older persons.

Authors:  John C Schoen; Kristine M Erlandson; Peter L Anderson
Journal:  Expert Opin Drug Metab Toxicol       Date:  2013-03-20       Impact factor: 4.481

4.  Perspectives on genetic and genomic technologies in an academic medical center: the duke experience.

Authors:  Sara Huston Katsanis; Mollie A Minear; Allison Vorderstrasse; Nancy Yang; Jason W Reeves; Tejinder Rakhra-Burris; Robert Cook-Deegan; Geoffrey S Ginsburg; Leigh Ann Simmons
Journal:  J Pers Med       Date:  2015-04-03

5.  Global HIV/AIDS Clinical and Translational Pharmacology.

Authors:  Gene D Morse; Gary Maartens; Charles Chiedza Maponga; Qing Ma
Journal:  AIDS Res Treat       Date:  2012-07-18

Review 6.  Genomic architecture of HIV-1 infection: current status & challenges.

Authors:  Gurvinder Kaur; Gaurav Sharma; Neeraj Kumar; Mrinali H Kaul; Rhea A Bansal; Madhu Vajpayee; Naveet Wig; Surender K Sharma; Narinder K Mehra
Journal:  Indian J Med Res       Date:  2013-11       Impact factor: 2.375

7.  Association of self-reported race with AIDS death in continuous HAART users in a cohort of HIV-infected women in the United States.

Authors:  Kerry Murphy; Donald R Hoover; Qiuhu Shi; Mardge Cohen; Monica Gandhi; Elizabeth T Golub; Deborah R Gustafson; Celeste Leigh Pearce; Mary Young; Kathryn Anastos
Journal:  AIDS       Date:  2013-09-24       Impact factor: 4.177
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.